Memorial Sloan Kettering Cancer Center
M

Hematopoietic Stem Cell Transplant: Difference Between AutoHSCT and AlloHSCT, Overcoming AE of Mismatched HSCT, Prognostic Models & Conditioning Regimen Effects

By Memorial Sloan Kettering Cancer Center FEATURING Miguel-Angel Perales
By Memorial Sloan Kettering Cancer Center FEATURING Miguel-Angel Perales
45 views
March 25, 2020
Comments 0
Login to view comments. Click here to Login

Related Videos

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.4K views
11:35

Prevention and Management of Post-SCT Relapse in Acute Leukemias

Vanderbilt University Medical Center (VUMC)

A. Jallouk

254 views
23:15

Is Post-HSCT Maintenance the SOC for AML?

Rush University Medical Center

M. Levis

302 views
23:37

Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6

Rush University Medical Center

E. Bhaimia

333 views
09:42

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Pr…

2024 ASCO® Annual Meeting Insights Hub

M. Al Malki

274 views
25:38

Allo-HSCT Conditioning Regimens: Current Status and Future Directions

Rush University Medical Center

C. Brunstein

261 views
22:30

Selection and Sequencing of Chronic GVHD Therapy

Rush University Medical Center

S. Kosuri

257 views
23:51

Pre-Transplant Management of High-Risk AML

Vanderbilt University Medical Center (VUMC)

K. Fedorov

96 views
40:21

Overview of Hematopoietic Cell Transplantation

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

R. Salit

769 views
07:22

Steroid-Refractory GvHD Management: When to Switch From Steroids

Giuseppe Francesco Milone

74 views
07:44

Correlation of PROs and Organ Response in Belumosudil-Treated cGVHD:…

Levanto Schachter

136 views
17:42

Managing Relapse After CAR-T Therapy in Lymphoma: Strategies and Con…

Vanderbilt University Medical Center (VUMC)

B. Dholaria

78 views
15:27

Age Limits in Stem Cell Transplants and Cell Therapy

Vanderbilt University Medical Center (VUMC)

R. Jayani

66 views
08:08

Unmet Needs in GvHD and the Role of Axatilimab

Jose Perez Simon

75 views
16:18

Understanding New Strategies to Prevent and Manage Chronic GVHD

2024 ASCO® Annual Meeting Insights Hub

B. Hamilton

68 views
16:55

SOHO 2023 Post-Transplant Maintenance Therapy for Patients With AML:…

SOHO 2023 Eleventh Annual Meeting

B. Oran

180 views
06:18

CSF1R's Role in Modulating Inflammation and Fibrosis in cGVHD

Robert Zeiser

51 views
08:43

Maintaining QoL in Chronic GvHD

Nandita Khera

50 views
14:34

Yale Cancer Center Allogeneic Stem Cell Transplantation Updates

Yale Cancer Center

L. Bachegowda

70 views
09:06

Debates in Ph+ ALL: Allo-SCT Is Not Necessary Upfront in Adult Patie…

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Jabbour

37 views
AUTOPLAY